» Articles » PMID: 15672000

Expectation of Pregnancy Outcome Among Mature Women

Overview
Publisher Elsevier
Date 2005 Jan 27
PMID 15672000
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Increasing numbers of mature women are achieving pregnancy largely through assisted reproductive technology (ART). Our objective was to investigate women over 45 years of age to determine the impact of pregnancy complications on newborn outcome.

Study Design: A study of women older than 45 years at their estimated date of confinement (EDC) was compared with a control group under 36 years at their EDC, matched by parity and plurality. All study patients and controls received uniform obstetric management through a single maternal fetal practice. The primary outcome was gestational age at birth stratified by plurality; secondary outcomes included birth weight, NICU days, composite neonatal morbidity, and a variety of obstetric complications. Wilcoxon signed rank and McNemar's tests were used as appropriate; logistic regression was used to calculate odds ratios (ORs) and CIs. Statistical significance was assumed for P < .05.

Results: Fifty study and control patients were identified over a 5-year period. Study patients were older than controls, but the difference in "gamete" age was not significant. There was significantly more assisted reproduction (donor egg) and preeclampsia among study patients. Importantly, gestational age at birth and birth weights stratified by plurality were not different (86% power to detect 2-week gestational age difference, alpha 0.05). Hospital days, NICU days, and composite neonatal morbidity were not different between study patients and controls.

Conclusion: When controlled for parity and plurality, mature women over 45 years conceiving largely through ART with donor eggs can expect newborn outcomes similar to younger women cared for in the same setting of a high-risk maternal-fetal practice.

Citing Articles

Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis.

Schwarze J, Borda P, Vasquez P, Ortega C, Villa S, Crosby J JBRA Assist Reprod. 2017; 22(1):15-19.

PMID: 29266893 PMC: 5844654. DOI: 10.5935/1518-0557.20180001.


Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden.

Elenis E, Sydsjo G, Skalkidou A, Lampic C, Skoog Svanberg A BMC Pediatr. 2016; 16(1):170.

PMID: 27769207 PMC: 5073900. DOI: 10.1186/s12887-016-0708-5.


A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Saito S, Nakabayashi Y, Nakashima A, Shima T, Yoshino O Semin Immunopathol. 2016; 38(6):687-697.

PMID: 27324236 DOI: 10.1007/s00281-016-0577-x.


Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis.

Blazquez A, Garcia D, Rodriguez A, Vassena R, Figueras F, Vernaeve V J Assist Reprod Genet. 2016; 33(7):855-63.

PMID: 27007875 PMC: 4930777. DOI: 10.1007/s10815-016-0701-9.


Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden.

Elenis E, Skoog Svanberg A, Lampic C, Skalkidou A, Akerud H, Sydsjo G BMC Pregnancy Childbirth. 2015; 15:247.

PMID: 26450684 PMC: 4598963. DOI: 10.1186/s12884-015-0687-9.